Deutsche Bank
IMRX icon

Deutsche Bank’s Immuneering IMRX Stock Holding History

Deutsche Bank’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Buy
+52,306
New +$265K ﹤0.01% 3115
2024
Q2 		– Sell
-11,382
Closed -$32.9K – 3624
2024
Q1 		$32.9K Sell
11,382
-462
-4% -$2.59K ﹤0.01% 3460
2023
Q4 		$87.1K Hold
11,844
– – ﹤0.01% 3281
2023
Q3 		$91K Buy
11,844
+10,793
+1,027% +$99.2K ﹤0.01% 3201
2023
Q2 		$10.7K Buy
+1,051
New +$10.1K ﹤0.01% 3647
2022
Q2 		– Sell
-10,442
Closed -$68K – 4217
2022
Q1 		$68K Buy
10,442
+5,420
+108% +$52.1K ﹤0.01% 3730
2021
Q4 		$81K Buy
5,022
+270
+6% +$6.57K ﹤0.01% 3788
2021
Q3 		$126K Buy
+4,752
New +$128K ﹤0.01% 3801

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Deutsche Bank's IMRX Position: Q2 2026 in Review

Deutsche Bank opened a new position in Immuneering (IMRX) in Q2 2026: 52,306 shares worth $261K. The stake represents ﹤0.01% of the portfolio and ranks #3115 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in IMRX as recently as Q1 2024.

Deutsche Bank first reported a position in IMRX in Q3 2021 and has held it in 8 quarters since. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Deutsche Bank held 52,306 shares of Immuneering worth $261K as of Q2 2026.
  • Immuneering was a new Deutsche Bank position in Q2 2026.
  • Immuneering made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3115 holding.
  • Deutsche Bank first reported a position in Immuneering in Q3 2021 and has held it in 8 quarters since.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.